TCL Archive In Brief: Reauthorization May Be Wrapped Up This Week As House, Senate Work Toward Compromise October 14, 1988
TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive In Brief: NCI’s First “Zero Based” Budget request Asks For $1.036 Billion; Grants Get Extra $1 Million September 23, 1977
